Literature DB >> 32338581

Comparison of methods for the isolation of cell-free DNA from cell culture supernatant.

Abel Jacobus Bronkhorst1, Vida Ungerer1, Stefan Holdenrieder1.   

Abstract

In vitro characterization of cell-free DNA using two-dimensional cell culture models is emerging as an important step toward an improved understanding of the physical and biological characteristics of cell-free DNA in human biology. However, precise measurement of the cell-free DNA in cell culture medium is highly dependent on the efficacy of the method used for DNA purification, and is often a juncture of experimental confusion. Therefore, in this study, we compared six commercially available cell-free DNA isolation kits for the recovery of cell-free DNA from the cell culture supernatant of a human bone cancer cell line (143B), including two magnetic bead-based manual kits, one automated magnetic bead-based extraction method, and three manual spin-column kits. Based on cell-free DNA quantitation and sizing, using the Qubit dsDNA HS assay and Bioanalyzer HS DNA assay, respectively, the different methods showed significant variability concerning recovery, reproducibility, and size discrimination. These findings highlight the importance of selecting a cell-free DNA extraction method that is appropriate for the aims of a study. For example, mutational analysis of cell-free DNA may be enhanced by a method that favors a high yield or is biased toward the isolation of short cell-free DNA fragments. In contrast, quantitative analysis of cell-free DNA in a comparative setting (e.g. measuring the fluctuation of cell-free DNA levels over time) may require the selection of a cell-free DNA isolation method that forgoes a high recovery for high reproducibility and minimal size bias.

Entities:  

Keywords:  Liquid biopsy; cell culture; cell-free DNA; cell-free DNA isolation; circulating tumor DNA; in vitro

Mesh:

Substances:

Year:  2020        PMID: 32338581     DOI: 10.1177/1010428320916314

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  8 in total

Review 1.  The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.

Authors:  Ugur Gezer; Abel J Bronkhorst; Stefan Holdenrieder
Journal:  Diagnostics (Basel)       Date:  2022-06-01

2.  DNA Sequencing from Subcritical Concentration of Cell-Free DNA Extracted from Electrowetting-on-Dielectric Platform.

Authors:  Anand Baby Alias; Hong-Yuan Huang; Yi-Wen Wang; Kai-Ti Lin; Pei-Jhen Lu; Tzu-Hui Wu; Pei-Shin Jiang; Chien-An Chen; Da-Jeng Yao
Journal:  Micromachines (Basel)       Date:  2022-03-25       Impact factor: 3.523

3.  Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA.

Authors:  Mohammad Amin Kerachian; Marjan Azghandi; Sina Mozaffari-Jovin; Alain R Thierry
Journal:  Clin Epigenetics       Date:  2021-10-18       Impact factor: 6.551

Review 4.  Future perspectives of uveal melanoma blood based biomarkers.

Authors:  Aaron B Beasley; Fred K Chen; Timothy W Isaacs; Elin S Gray
Journal:  Br J Cancer       Date:  2022-02-21       Impact factor: 9.075

Review 5.  Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets.

Authors:  Elena-Georgiana Dobre; Carolina Constantin; Monica Neagu
Journal:  J Pers Med       Date:  2022-07-13

6.  Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line.

Authors:  Vida Ungerer; Abel J Bronkhorst; Carsten Uhlig; Stefan Holdenrieder
Journal:  Diagnostics (Basel)       Date:  2022-08-04

7.  Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients.

Authors:  Elmo W I Neuberger; Alexandra Brahmer; Tobias Ehlert; Katrin Kluge; Keito F A Philippi; Simone C Boedecker; Julia Weinmann-Menke; Perikles Simon
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

8.  Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness.

Authors:  Guinevere Q Lee
Journal:  Viruses       Date:  2021-09-19       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.